| LINC00472 suppresses non-small cell lung cancer progression via regulating miR-23a-3p/CCL22 axis. | LINC00472 suppresses non-small cell lung cancer progression via regulating miR-23a-3p/CCL22 axis.
Yang S, Liu Y, Li Y, Ji X, Yun Y, Yang G, Liu H, Liang X, Dang H. | 10/9/2024 |
| LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis. | LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis.
Liu X, Ma X, Li H, Wang Y, Mao M, Liang C, Hu Y., Free PMC Article | 04/23/2022 |
| Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis. | Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis.
Zou C, Lv X, Wei H, Wu S, Song J, Tang Z, Liu S, Li X, Ai Y., Free PMC Article | 04/16/2022 |
| LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer. | LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer.
Bi C, Wang G., Free PMC Article | 02/19/2022 |
| Gene expression profiling after LINC00472 overexpression in an NSCLC cell line1. | Gene expression profiling after LINC00472 overexpression in an NSCLC cell line1.
Seo D, Roh J, Chae Y, Kim W. | 02/5/2022 |
| LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1. | LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
Deng X, Xiong W, Jiang X, Zhang S, Li Z, Zhou Y, Xiang B, Zhou M, Li X, Li G, Zeng Z, Gong Z., Free PMC Article | 09/11/2021 |
| LINC00472 promotes osteogenic differentiation and alleviates osteoporosis by sponging miR-300 to upregulate the expression of FGFR2. | LINC00472 promotes osteogenic differentiation and alleviates osteoporosis by sponging miR-300 to upregulate the expression of FGFR2.
Guo HL, Wang X, Yang GY, Wu YY, Chen YC, Zhan HS, Zhao YF. | 04/24/2021 |
| Down-regulation of long noncoding RNA LINC00472 alleviates sepsis-induced acute hepatic injury by regulating miR-373-3p/TRIM8 axis. | Down-regulation of long noncoding RNA LINC00472 alleviates sepsis-induced acute hepatic injury by regulating miR-373-3p/TRIM8 axis.
Li L, He Y, He XJ, Bi MR, Qi YH, Zhu WW. | 02/6/2021 |
| LINC00472 suppressed proliferation, migration and invasion of hepatocellular carcinoma cells. MiR-93-5p was a direct target of LINC00472, and miR-93-5p directly targeted PDCD4. The miR-93-5p/PDCD4 pathway mediated the suppressing role of LINC00472 in hepatocellular carcinoma cells. As an important tumor suppressor, LINC00472 could be used as a bio-marker for HCC therapy. | Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway.
Chen C, Zheng Q, Kang W, Yu C. | 07/11/2020 |
| Dysregulated expression of LINC00472 in atrial fibrillation patients could up-regulate the expression of miR-24, a competing endogenous RNA of LINC00472, resulting in the deregulation of JP2 and RyR2, which may contribute to the pathogenesis of AF. | LncRNA-LINC00472 contributes to the pathogenesis of atrial fibrillation (Af) by reducing expression of JP2 and RyR2 via miR-24.
Wang LY, Shen H, Yang Q, Min J, Wang Q, Xi W, Yin L, Le SG, Zhang YF, Xiao J, Wang ZN, Ji GY. | 04/25/2020 |
| This study identified EA15, MIR22, and LINC00472 may serve as the potential diagnostic markers of diabetic nephropathy. | EA15, MIR22, LINC00472 as diagnostic markers for diabetic kidney disease.
Wang YZ, Zhu DY, Xie XM, Ding M, Wang YL, Sun LL, Zhang N, Shen E, Wang XX. | 04/18/2020 |
| These results may provide a clue to further research into the function and regulatory mechanism of LINC00472 in colorectal cancer. | Regulatory network analysis of LINC00472, a long noncoding RNA downregulated by DNA hypermethylation in colorectal cancer.
Chen L, Zhang W, Li DY, Wang X, Tao Y, Zhang Y, Dong C, Zhao J, Zhang L, Zhang X, Guo J, Zhang X, Liao Q. | 12/7/2019 |
| The study demonstrates that ERa upregulates LINC00472 which suppresses the phosphorylation of NF-kappaB, and suggests that endocrine treatment may lower LINC00472 and increase NF-kappaB activities, leading to tumor progression and disease recurrence | ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer.
Wang Z, Katsaros D, Biglia N, Shen Y, Loo L, Yu X, Lin H, Fu Y, Chu WM, Fei P, Ni Y, Jia W, Deng X, Qian B, Yu H., Free PMC Article | 11/16/2019 |
| Study demonstrated that the cytosolic lncRNA P53RRA is downregulated in cancers and functions as a tumor suppressor by inhibiting cancer progression. P53RRA bound G3BP1 and cytosolic P53RRA-G3BP1 interaction displaced p53 from a G3BP1 complex, resulting in greater p53 retention in the nucleus, which led to cell-cycle arrest, apoptosis, and ferroptosis. | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53.
Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang Y, Shi Y, Shen Y, Liu X, Lai W, Yang R, Xiao D, Cheng Y, Liu S, Zhou H, Cao Y, Yu W, Muegge K, Yu H, Tao Y., Free PMC Article | 08/10/2019 |
| LINC00472 is functionally a tumor suppressor.LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. | LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer.
Shen Y, Wang Z, Loo LW, Ni Y, Jia W, Fei P, Risch HA, Katsaros D, Yu H., Free PMC Article | 09/10/2016 |
| Patients with high LINC00472 had significantly reduced risk of relapse and death, and they also had more favorable subtypes and better responses to adjuvant chemo- or hormonal therapy. | Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer.
Shen Y, Katsaros D, Loo LW, Hernandez BY, Chong C, Canuto EM, Biglia N, Lu L, Risch H, Chu WM, Yu H., Free PMC Article | 02/13/2016 |